The report "Pharmaceutical Glass Packaging Market by Type (Ampoules, Vials, Bottles, Syringes), Material (Type I, Type II, Type III), Drug Type, Manufacturing Process, Application (Injectables, Vaccines, Biologics), End user, and Region - Global Forecast To 2030" is projected to grow from USD 3.10 billion in 2025 to USD 6.36 billion by 2030, at a CAGR of 15.5% during the forecast period.
Browse 130 market data Tables and 59 Figures spread through 200 Pages and in-depth TOC on "Pharmaceutical Glass Packaging Market, By Type (Ampoules, Vials, Bottles, Syringes), Material (Type I, Type II, Type III), Drug Type, Manufacturing Process, Application (Injectables, Vaccines, Biologics), End user, and Region - Global Forecast To 2030"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/pharmaceutical-glass-packaging-market-43663487.html
The pharmaceutical glass packaging market has experienced notable growth, driven by rising demand for glass packaging due to its inert properties, making it ideal for preserving the efficacy and stability of high-potency drugs such as biologics. The increasing use of glass in drug delivery systems, especially in vials and ampoules for injectables, further supports the market's expansion. Technological advancements in glass treatment processes are also enhancing the application scope of glass packaging, ensuring better drug protection and patient safety. However, the high cost of production and the fragility of glass, leading to handling challenges, may slightly hinder market growth. On a positive note, advancements in coating technologies that minimize glass breakage and enhance product shelf life are likely to drive overall growth in the pharmaceutical glass packaging market.
Asia Pacific to be fastest-growing regional market for pharmaceutical glass packaging during the forecast period.
The pharmaceutical glass packaging market is segmented into North America, Europe, Asia Pacific, South America, and the Middle East & Africa. Among these, Asia Pacific is anticipated to be the fastest-growing regional market (17.0% CAGR), driven by increased healthcare investments and demand for sustainable packaging solutions. This approach reduces the need for costly imports and supports local pharmaceutical manufacturing. The comfort and safety provided by glass packaging for injectable drugs have significantly contributed to market growth. Additionally, the rising demand for secure and contamination-free packaging has further propelled the expansion of the pharmaceutical glass packaging market, particularly in the Asia Pacific region.
By type, ampoules and vials accounted for largest market share in 2025.
The market comprises various types, including ampoules, vials, glass bottles, and syringes, with ampoules and vials holding a larger market share, particularly in injectable drug packaging. This segment leads the market due to ongoing technological innovations in glass manufacturing and treatment processes, which enhance product integrity and ease of use, thereby improving drug safety and efficacy. The superior chemical and thermal properties of Type I neutral or borosilicate glass have made it the preferred choice for pharmaceutical applications. Key companies providing innovative, patient-centered solutions in this market include Schott AG (Germany), Gerresheimer AG (Germany), and Nipro Corporation (Japan), all of which maintain strong positions in the pharmaceutical glass packaging market.
The key players in the pharmaceutical glass packaging market include Schott AG (Germany), Gerresheimer AG (Germany), Nipro Corporation (Japan), Stevanato Group (Italy), SGD Pharma (France), Ardagh Group (Luxembourg), Bormioli Pharma (Italy), Owens-Illinois (US), Piramal Glass (India), and Corning Incorporated (US).
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: [email protected]
Visit Our Website: https://www.marketsandmarkets.com